Logo

Machine learning helps predict immunotherapy response in lymphoma patients

Machine learning helps predict immunotherapy response in lymphoma patients

Researchers with City of Hope and Memorial Sloan Kettering (MSK) Cancer Center have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) patient's likely response to chimeric antigen receptor (CAR) T cell therapy before starting the treatment, according to study results published in Nature Medicine.

👉 Full Story